New York S 8780: Requires certain kratom products to include a warning label

Bill Text

Bill Search and Legislative Information | New York State Assembly 

• 

• 

• 

• 

• 

• 

• 

• 

 Skip to main content 

 New York State Assembly

 Speaker Carl E. Heastie

 --> 
 --> 

 --> 

• 
 Assembly Members 

• 
 Legislative Info 

• 
 Public Hearings 

• 
 Speaker's Press 

• 
 Assembly Reports 

• 
 Committees & More 

• Bill Search Home
• Laws
• Legislative Calendar
• Public Hearing Schedule
• Assembly Calendars
• Assembly Committee Agenda 

 Javascript must be enabled to properly view this page. 

 Bill No.: 

• Summary 
• Actions 
• Committee&nbspVotes 
• Floor&nbspVotes 
• Memo 
• Text 
• LFIN 
• Chamber&nbspVideo/Transcript 
S08780 Summary:

BILL NOS08780 

&nbsp

SAME ASSAME AS A09443

&nbsp

SPONSORSKOUFIS

&nbsp

COSPNSR

&nbsp

MLTSPNSR

&nbsp

Amd §398-g, Gen Bus L (as proposed in S.8285 & A.5852-A)

&nbsp

Requires certain kratom products to include a warning label with disclosures including, but not limited to, that kratom may be addictive and to keep it out of reach of children.

Go to top S08780 Actions:

BILL NOS08780 

&nbsp

01/08/2026REFERRED TO RULES

01/27/2026ORDERED TO THIRD READING CAL.152

02/03/2026SUBSTITUTED BY A9443

&nbspA09443 AMEND= Steck

&nbsp01/06/2026referred to consumer affairs and protection

&nbsp01/07/2026referred to consumer affairs and protection

&nbsp01/12/2026reported referred to codes

&nbsp01/13/2026reported referred to rules

&nbsp01/13/2026reported 

&nbsp01/13/2026rules report cal.23

&nbsp01/13/2026ordered to third reading rules cal.23

&nbsp01/20/2026passed assembly

&nbsp01/20/2026delivered to senate

&nbsp01/20/2026REFERRED TO RULES

&nbsp02/03/2026SUBSTITUTED FOR S8780

&nbsp02/03/20263RD READING CAL.152

&nbsp02/03/2026PASSED SENATE

&nbsp02/03/2026RETURNED TO ASSEMBLY

&nbsp02/13/2026delivered to governor

&nbsp02/13/2026signed chap.12

Go to topS08780 Committee&nbspVotes:

Go to topS08780 Floor&nbspVotes:

There are no Assembly votes for this bill in this legislative session.

Go to topS08780 Text:

 STATE OF NEW YORK
 ________________________________________________________________________

 8780

 IN SENATE

 January 8, 2026
 ___________

 Introduced by Sen. SKOUFIS -- read twice and ordered printed, and when
 printed to be committed to the Committee on Rules

 AN ACT to amend the general business law, in relation to regulating the
 sale of kratom products

 The People of the State of New York, represented in Senate and Assem-
 bly, do enact as follows:

 1 Section 1. Section 398-g of the general business law, as added by a
 2 chapter of the laws of 2025 amending the general business law relating
 3 to regulating the sale of kratom products, as proposed in legislative
 4 bills numbers S. 8285 and A. 5852-A, is amended to read as follows:
 5 § 398-g. Kratom package labeling. 1. For the purposes of this section,
 6 [the following terms shall have the following meanings:
 7 (a)] "Kratom" means [both] any part of the plant Mitragyna speciosa,
 8 [a tree native to Southeast Asia, and the products derived from its
 9 leaves that are marketed as herbal supplements.
 10 (b) "All natural" means a product that contains no artificial ingredi-
 11 ents or added colors and is minimally processed.] whether growing or
 12 not, and any compound, manufacture, salt, derivative, mixture, or prepa-
 13 ration of such plant or synthesized or semi-synthesized preparations of
 14 mitragynine or 7-hydroxymitragynine, their derivatives, salts, esters,
 15 and isomers.
 16 2. [On each package of any kratom product sold or delivered by a
 17 manufacturer within this state on or after January first, two thousand
 18 twenty-six, there shall be printed thereon or attached thereto a warning
 19 of such product's lack of federal food and drug administration approval
 20 and such kratom products' known side effects. Such warning shall be in
 21 a font not less than twelve-point type and in a color in contrast with
 22 the package containing such kratom product, and shall contain the
 23 following statement:
 24 "WARNING This product has not been approved by the FDA. Side effects
 25 may include nausea, agitation, hallucinations, difficulty breathing,
 26 liver damage, and death"] No person, firm, partnership, association, or
 27 corporation shall manufacture, distribute, sell or offer for sale at
 28 retail within the state any product containing kratom unless there is

 EXPLANATION--Matter in italics (underscored) is new; matter in brackets
 [ ] is old law to be omitted.
 LBD09239-04-6

 S. 8780 2

 1 printed thereon such packaging or attached thereto a label disclosing
 2 the following:
 3 (a) the name and address for the place of business of the manufacturer
 4 or distributor of the kratom product;
 5 (b) the full list of ingredients in the kratom product;
 6 (c) the following disclosures:
 7 (i) that sale or distribution by individuals who are under twenty-one
 8 years of age is prohibited under the public health law;
 9 (ii) that use by individuals who are pre